Troubled Spanish pharma company Grifols says it may go private for $6 billion
Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.
Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.
